Allred Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $428K | Sell |
17,760
-134
| -0.7% | -$3.5K | 0.14% | 115 |
|
|
2026
Q1 | $502K | Buy |
17,894
+166
| +0.9% | +$4.42K | 0.18% | 101 |
|
|
2025
Q4 | $441K | Buy |
17,728
+501
| +3% | +$12.6K | 0.16% | 110 |
|
|
2025
Q3 | $439K | Buy |
17,227
+148
| +0.9% | +$3.65K | 0.15% | 118 |
|
|
2025
Q2 | $414K | Sell |
17,079
-202
| -1% | -$4.71K | 0.15% | 112 |
|
|
2025
Q1 | $438K | Buy |
17,281
+98
| +0.6% | +$2.56K | 0.18% | 107 |
|
|
2024
Q4 | $456K | Sell |
17,183
-703
| -4% | -$19.1K | 0.18% | 114 |
|
|
2024
Q3 | $518K | Sell |
17,886
-522
| -3% | -$15.2K | 0.2% | 100 |
|
|
2024
Q2 | $515K | Sell |
18,408
-40
| -0.2% | -$1.1K | 0.2% | 105 |
|
|
2024
Q1 | $512K | Sell |
18,448
-383
| -2% | -$10.6K | 0.2% | 107 |
|
|
2023
Q4 | $542K | Sell |
18,831
-2,261
| -11% | -$68.3K | 0.24% | 92 |
|
|
2023
Q3 | $700K | Sell |
21,092
-7
| -0% | -$248 | 0.35% | 60 |
|
|
2023
Q2 | $774K | Buy |
21,099
+98
| +0.5% | +$3.81K | 0.38% | 55 |
|
|
2023
Q1 | $857K | Buy |
21,001
+576
| +3% | +$24.9K | 0.45% | 51 |
|
|
2022
Q4 | $1.05M | Buy |
20,425
+387
| +2% | +$18.6K | 0.57% | 42 |
|
|
2022
Q3 | $876K | Sell |
20,038
-1,264
| -6% | -$61.4K | 0.55% | 44 |
|
|
2022
Q2 | $1.12M | Sell |
21,302
-720
| -3% | -$36.7K | 0.7% | 38 |
|
|
2022
Q1 | $1.14M | Buy |
22,022
+1,547
| +8% | +$80.3K | 0.6% | 43 |
|
|
2021
Q4 | $1.21M | Sell |
20,475
-1,248
| -6% | -$61.8K | 0.58% | 39 |
|
|
2021
Q3 | $934K | Sell |
21,723
-4,108
| -16% | -$182K | 0.49% | 53 |
|
|
2021
Q2 | $1.01M | Sell |
25,831
-357
| -1% | -$13.9K | 0.5% | 54 |
|
|
2021
Q1 | $949K | Buy |
26,188
+3,116
| +14% | +$111K | 0.43% | 56 |
|
|
2020
Q4 | $849K | Sell |
23,072
-3,454
| -13% | -$127K | 0.46% | 60 |
|
|
2020
Q3 | $923K | Buy |
26,526
+2,166
| +9% | +$75.9K | 0.56% | 49 |
|
|
2020
Q2 | $755K | Sell |
24,360
-942
| -4% | -$32K | 0.48% | 61 |
|
|
2020
Q1 | $783K | Sell |
25,302
-1,480
| -6% | -$50.4K | 0.61% | 48 |
|
|
2019
Q4 | $996K | Sell |
26,782
-2,021
| -7% | -$72K | 0.54% | 44 |
|
|
2019
Q3 | $968K | Buy |
28,803
+3,083
| +12% | +$112K | 0.59% | 47 |
|
|
2019
Q2 | $1.08M | Sell |
25,720
-220
| -0.8% | -$8.74K | 0.62% | 43 |
|
|
2019
Q1 | $1.06M | Sell |
25,940
-741
| -3% | -$29.7K | 0.6% | 48 |
|
|
2018
Q4 | $1.1M | Buy |
+26,681
| New | +$1.11M | 0.74% | 37 |
|
Other funds holding PFE
Allred Capital Management's PFE Position: Q2 2026 in Review
Allred Capital Management reduced its Pfizer (PFE) stake by 0.75% in Q2 2026, selling an estimated $3.5K and leaving 17,760 shares worth $428K. The position accounts for 0.14% of the portfolio, ranked #115.
Allred Capital Management first reported a position in PFE in Q4 2018 and has held it in 31 quarters since. The position peaked at $1.21M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Allred Capital Management held 17,760 shares of Pfizer worth $428K as of Q2 2026.
- Allred Capital Management sold 134 Pfizer shares in Q2 2026, an estimated $3.5K.
- Pfizer made up 0.14% of Allred Capital Management's portfolio in Q2 2026, its #115 holding.
- Allred Capital Management first reported a position in Pfizer in Q4 2018 and has held it in 31 quarters since.
- Allred Capital Management's Pfizer position peaked at $1.21M in Q4 2021.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Allred Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.